美国 · SEC FORM 4
Innovative Eyewear Inc
LUCY · Nasdaq · CIK 0001808377 · Healthcare · Medical Instruments & Supplies
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
12 同一窗口内观察到的 Form 4 交易行
7 sales · 5 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2026-01-21 · Gross Harrison R. · $2.0K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出中等
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Cohen David EricChief Technology Officer
▼○▼
Gayle OswaldChief Financial Officer
○▼
Dabrowski KonradChief AI & Growth Officer
○▼
Abondano JoaquinChief Operating Officer
○▼
Gross Harrison R.Chief Executive Officer
○▼
● 买入▼ 卖出○ 其他
—
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-01-21 · Gross Harrison R..
近期 Form 4 活动
21买入
13卖出
10其他 Form 4 交易行
15SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出7 sale line(s) · 仅供背景
其他5 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 180,001
- 上期报告
- 158,090
- 日均成交量
- 189,566
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-01-21 | Gross Harrison R. | 买入 (P) | Common Stock | 1,500 | USD 1.32 | USD 1,980 | SEC 申报 ↗ |
| 2026-01-13 | Gayle Oswald | 买入 (P) | Common Stock | 1,000 | USD 1.67 | USD 1,669 | SEC 申报 ↗ |
| 2026-01-08 | Gross Harrison R. | 买入 (P) | Common Stock | 1,500 | USD 1.60 | USD 2,400 | SEC 申报 ↗ |
| 2026-01-08 | Dabrowski Konrad | 买入 (P) | Common Stock | 1,300 | USD 1.58 | USD 2,054 | SEC 申报 ↗ |
| 2026-01-07 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 643,505 | USD 1.79 | USD 1,151,874 | SEC 申报 ↗ |
| 2026-01-02 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 4,000 | USD 1.02 | USD 4,080 | SEC 申报 ↗ |
| 2026-01-02 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 1,262 | USD 0.97 | USD 1,224 | SEC 申报 ↗ |
| 2025-12-31 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 89,830 | USD 0.99 | USD 88,932 | SEC 申报 ↗ |
| 2025-12-30 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 11,303 | USD 1.08 | USD 12,207 | SEC 申报 ↗ |
| 2025-12-29 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 46,107 | USD 1.10 | USD 50,718 | SEC 申报 ↗ |
| 2025-12-26 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 90,709 | USD 1.22 | USD 110,665 | SEC 申报 ↗ |
| 2025-12-24 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 928 | USD 1.31 | USD 1,216 | SEC 申报 ↗ |
| 2025-12-23 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 32,958 | USD 1.33 | USD 43,834 | SEC 申报 ↗ |
| 2025-12-22 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 367 | USD 1.35 | USD 495 | SEC 申报 ↗ |
| 2025-12-19 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 4,835 | USD 1.37 | USD 6,624 | SEC 申报 ↗ |
Form 4 申报证据
44 transaction lines in the latest 365-day window; 143 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | Gross Harrison R. | 卖出 (S) | Common Stock | 13,974 | USD 0.70 | USD 9,756 | SEC 申报 ↗ |
| 2026-08-19 | Gross Harrison R. | 奖励／授予 (A) | Common Stock | 24,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-19 | Gayle Oswald | 卖出 (S) | Common Stock | 7,959 | USD 0.67 | USD 5,333 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | Gross Harrison R. | 卖出 (S) | Common Stock | 13,974 | USD 0.70 | USD 9,756 | SEC 申报 ↗ |
| 2026-08-19 | Gross Harrison R. | 奖励／授予 (A) | Common Stock | 24,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-19 | Gayle Oswald | 卖出 (S) | Common Stock | 7,959 | USD 0.67 | USD 5,333 | SEC 申报 ↗ |
| 2026-08-19 | Gayle Oswald | 奖励／授予 (A) | Common Stock | 16,233 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-19 | Dabrowski Konrad | 卖出 (S) | Common Stock | 6,935 | USD 0.69 | USD 4,785 | SEC 申报 ↗ |
| 2026-08-19 | Dabrowski Konrad | 奖励／授予 (A) | Common Stock | 20,900 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-19 | Cohen David Eric | 卖出 (S) | Common Stock | 6,136 | USD 0.68 | USD 4,172 | SEC 申报 ↗ |
| 2026-08-19 | Cohen David Eric | 奖励／授予 (A) | Common Stock | 18,200 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-19 | Abondano Joaquin | 卖出 (S) | Common Stock | 5,020 | USD 0.68 | USD 3,414 | SEC 申报 ↗ |
| 2026-08-19 | Abondano Joaquin | 奖励／授予 (A) | Common Stock | 14,800 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-06 | Cohen David Eric | 卖出 (S) | Common Stock | 1,860 | USD 1.17 | USD 2,176 | SEC 申报 ↗ |
| 2026-04-09 | Cohen David Eric | 卖出 (S) | Common Stock | 1,860 | USD 1.11 | USD 2,065 | SEC 申报 ↗ |
| 2026-04-02 | Gross Harrison R. | 卖出 (S) | Common Stock | 13,764 | USD 1.07 | USD 14,727 | SEC 申报 ↗ |
| 2026-04-02 | Gross Harrison R. | 奖励／授予 (A) | Common Stock | 24,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-02 | Gayle Oswald | 卖出 (S) | Common Stock | 7,574 | USD 1.07 | USD 8,104 | SEC 申报 ↗ |
| 2026-04-02 | Gayle Oswald | 奖励／授予 (A) | Common Stock | 16,233 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-02 | Dabrowski Konrad | 卖出 (S) | Common Stock | 6,692 | USD 1.06 | USD 7,094 | SEC 申报 ↗ |
| 2026-04-02 | Dabrowski Konrad | 奖励／授予 (A) | Common Stock | 20,900 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-02 | Cohen David Eric | 卖出 (S) | Common Stock | 5,913 | USD 1.04 | USD 6,150 | SEC 申报 ↗ |
| 2026-04-02 | Cohen David Eric | 奖励／授予 (A) | Common Stock | 18,200 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-02 | Abondano Joaquin | 卖出 (S) | Common Stock | 4,779 | USD 1.05 | USD 5,018 | SEC 申报 ↗ |
| 2026-04-02 | Abondano Joaquin | 奖励／授予 (A) | Common Stock | 14,800 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Gross Harrison R. | 买入 (P) | Common Stock | 1,500 | USD 1.32 | USD 1,980 | SEC 申报 ↗ |
| 2026-01-13 | Gayle Oswald | 买入 (P) | Common Stock | 1,000 | USD 1.67 | USD 1,669 | SEC 申报 ↗ |
| 2026-01-08 | Gross Harrison R. | 买入 (P) | Common Stock | 1,500 | USD 1.60 | USD 2,400 | SEC 申报 ↗ |
| 2026-01-08 | Dabrowski Konrad | 买入 (P) | Common Stock | 1,300 | USD 1.58 | USD 2,054 | SEC 申报 ↗ |
| 2026-01-07 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 643,505 | USD 1.79 | USD 1,151,874 | SEC 申报 ↗ |
| 2026-01-02 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 4,000 | USD 1.02 | USD 4,080 | SEC 申报 ↗ |
| 2026-01-02 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 1,262 | USD 0.97 | USD 1,224 | SEC 申报 ↗ |
| 2025-12-31 | Galkin Vladimir | 买入 (P) | Common Stock, par value $0.00001 | 89,830 | USD 0.99 | USD 88,932 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LUCY |
| CIK | 0001808377 |
| 行业 | Healthcare |
| 细分行业 | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3851 Ophthalmic Goods |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 143 transaction lines from 2024-08-19 to 2026-08-19 64 P purchase lines · 58 S sale lines · 21 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.